PlainPharmaWatch

CMS Open Payments · Program Year 2024

Hyhte Holdings Inc.

Hyhte Holdings Inc. reported $1,259,984.35 across General Payments, Research, and Ownership to 77 physicians and teaching hospitals across 77 transactions.

$1.3M
All-tracks total
77
Transactions
77
Recipients
+$174.8K
General Payments vs PY2023

Hyhte Holdings Inc. reported $1,259,984.35 across all CMS Open Payments tracks (General + Research + Ownership) to 77 physicians and teaching hospitals in Program Year 2024 - ranking #565 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,259,984.35, averaging $16.4K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer hyhte-holdings-inc Hyhte Holdings Inc.

$1.3M · #565/1,925 · 0.0% industry · PY2024

  • TOT $1.3M
  • RANK #565
  • SHARE 0.0%
  • TXN 77
  • RCP 77
  • CAT 1
  • GEN $1.3M
  • ΔGEN +$174.8K
  • TOP1 14.8%
  • PY 2024

Nearest volume peer: TearOptix, Inc. ($1.3M)

Ingeniumspine, LLC$1.3MHyhte Holdings Inc. (this)$1.3MTearOptix, Inc.$1.3MBioventus LLC$1.3MDiaSorin Molecular LLC$1.2M
All-tracks payment totals near Hyhte Holdings Inc. (CMS Open Payments PY2024)

Hyhte Holdings Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Hyhte Holdings Inc.'s CMS-reported General Payments increased by $174.8K (+16.1%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: HYHTE HOLDINGS INC.PY2023: HYHTE HOLDINGS INC.PY2024: Hyhte Holdings Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.1MPY2024$1.3M
PY2023
$1,085,207.27
PY2024
$1,259,984.35

What the Data Shows for Hyhte Holdings Inc.

$1,259,984.35: that is what Hyhte Holdings Inc. reported in payments to 77 physicians and teaching hospitals during Program Year 2024, spread across 77 transactions ($16.4K per transaction, $16.4K per recipient). The company sits at rank #565 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $1.3M, accounting for 100.0% of this company's General Payments and 77 transactions.

General Payment Breakdown by Type

"Royalty or License" leads Hyhte Holdings Inc.'s 1-category general-payment breakdown at $1.3M, 100.0% of the reported total.

How Hyhte Holdings Inc. divides its payments

General-payment categories, ordered by reported total

1. Royalty or License$1.3M
Payment Type Amount Transactions
Royalty or License $1.3M 77

Recipient Concentration in General Payments

The five largest recipient relationships account for $739,133.85 (58.7%) of $1,259,984.35 in this company's General Payments records across 22 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Hyhte Holdings Inc.

The five named recipients with the highest reported General Payments from this company

Christopher Ames$186.1KConstantine Toumbis$184.1KAdam Brant$156.6KLuis Duarte$116.2KDarin Awaya$96.1K
  1. 1

    Christopher Ames

    $186,111.77 across 4 reported transactions

  2. 2

    Constantine Toumbis

    $184,095.09 across 4 reported transactions

  3. 3

    Adam Brant

    $156,625.73 across 4 reported transactions

  4. 4

    Luis Duarte

    $116,154.12 across 8 reported transactions

  5. 5

    Darin Awaya

    $96,147.14 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Hyhte Holdings Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Hyhte Holdings Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Hyhte Holdings Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Hyhte Holdings Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.